UPDATE: Biogen (BIIB) PT Raised to $256 at RBC Capital After SAGE Deal Call
Tweet Send to a Friend
(Updated - December 1, 2020 6:58 AM EST)
RBC Capital analyst Brian Abrahams raised the price target on Biogen ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
RBC Capital analyst Brian Abrahams raised the price target on Biogen ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
